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CRISPR-Cas systems are bacterial defenses against foreign nucleic acids derived
from bacteriophages, plasmids or other sources. These systems are targeted in an
RNA-dependent, sequence-specific manner, and are also adaptive, providing protection
against previously encountered foreign elements. In addition to their canonical function in
defense against foreign nucleic acid, their roles in various aspects of bacterial physiology
are now being uncovered. We recently revealed a role for a Cas9-based Type II CRISPR-Cas
system in the control of endogenous gene expression, a novel form of prokaryotic
gene regulation. Cas9 functions in association with two small RNAs to target and alter
the stability of an endogenous transcript encoding a bacterial lipoprotein (BLP). Since
BLPs are recognized by the host innate immune protein Toll-like Receptor 2 (TLR2),
CRISPR-Cas-mediated repression of BLP expression facilitates evasion of TLR2 by the
intracellular bacterial pathogen Francisella novicida, and is essential for its virulence.
Here we describe the Cas9 regulatory system in detail, as well as data on its role in
controlling virulence traits of Neisseria meningitidis and Campylobacter jejuni. We also
discuss potential roles of CRISPR-Cas systems in the response to envelope stress and
other aspects of bacterial physiology. Since ∼45% of bacteria and ∼83% of Archaea
encode these machineries, the newly appreciated regulatory functions of CRISPR-Cas
systems are likely to play broad roles in controlling the pathogenesis and physiology of
diverse prokaryotes.
Keywords: CRISPR-Cas, Cas9, post-transcriptional regulation of gene expression, bacterial pathogenesis,
Francisella novicida
INTRODUCTION
CRISPR (clustered, regularly interspaced, short, palindromic
repeats)—Cas (CRISPR-associated) systems are adaptive,
sequence specific, nucleic acid restriction machineries found in
many bacteria and Archaea (Makarova et al., 2011). These sys-
tems provide prokaryotes with an effective defense against mobile
genetic elements, in particular bacteriophages, plasmids, and
transposons (Barrangou et al., 2007; Marraffini and Sontheimer,
2008; Garneau et al., 2010; Bikard et al., 2012). The defining
feature of CRISPR-Cas systems is a chromosomal array consisting
of short, repetitive, and sometimes palindromic sequences, which
are interspersed by short, unique, spacer sequences. Such arrays
were first identified over 25 years ago, during sequencing of the
iap gene in E. coli (Ishino et al., 1987), and subsequently named
CRISPR arrays (which are transcribed into CRISPR RNAs, or
crRNA). However, these stretches of repeat sequences had no
known function until 2007, when Barrangou et al. demonstrated
that they function with associated cas genes as adaptive restriction
machineries against bacteriophage infection (Barrangou et al.,
2007).
Over the past 5 years, incredible progress has beenmade in elu-
cidating the molecular mechanisms of action of CRISPR-Cas sys-
tems, revealing their roles in a form of RNA-directed nucleic acid
interference. Briefly, the entire crRNA array is transcribed as a sin-
gle, long transcript, that is subsequently processed into individual
crRNAs (Figure 1), each containing one spacer sequence and por-
tions of the repeat sequence at both the 5′ and 3′ ends (Golovliov
et al., 2003; Brouns et al., 2008; Hale et al., 2009; Pougach et al.,
2010; Deltcheva et al., 2011). Cas proteins interact with the pro-
cessed crRNAs which target the resulting RNA:protein complex to
foreign nucleic acids (Figure 1). Specifically, the spacer sequence
in each crRNA hybridizes to complementary sequences in nucleic
acid targets, ultimately triggering the cleavage of the target by
the associated Cas proteins (Figure 1) (Barrangou et al., 2007;
Marraffini and Sontheimer, 2008; Garneau et al., 2010; Bikard
et al., 2012).
CRISPR-Cas systems are also uniquely adaptive. In a currently
incompletely defined process, it is thought that the Cas proteins
Cas1 and Cas2 recognize foreign nucleic acid that has entered
the prokaryotic cell, and process it into a new spacer sequence(s)
that is then integrated into the crRNA array (Figure 1) (Datsenko
et al., 2012; Fineran and Charpentier, 2012). This allows the
individual bacterial cell and its progeny to subsequently tar-
get the foreign nucleic acid if encountered again (Barrangou
et al., 2007; Datsenko et al., 2012; Yosef et al., 2012). This
provides prokaryotes encoding CRISPR-Cas systems with an
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FIGURE 1 | Function of the Type II CRISPR-Cas system in adaptive nucleic
acid restriction. (A) Foreign DNA is recognized by Cas1 and Cas2 and is
processed intoanewspacersequence (red)within theCRISPRarray (Adaptation
phase, blue). (B) To restrict foreign DNA, the CRISPR array is transcribed as a
single transcript (pre-crRNA array) andmatured into small targeting crRNAs in a
process requiring RNase III and tracrRNA. The dsRNA complex of crRNA and
tracrRNA is associated with Cas9 and the spacer sequence within the crRNA
can hybridize to complementary DNA sequences. Cas9 then mediates
cleavage of the targeted DNA downstream of the proto-spacer adjacent motif,
or PAM, highlighted by the red circle (Effector phase, pink).
unprecedented adaptive mechanism to prepare for, and mitigate,
future threats.
Interestingly, some bacteria encode spacers within the crRNA
array that have sequence identity to chromosomal loci. In many
such cases, the associated cas genes have degenerated, providing
an explanation for why the chromosome itself is not targeted
(Stern et al., 2010). However, in some bacteria, this does not
appear to be the case, and the associated cas genes are still intact.
Due to their functionality in sequence-specifically targeting and
cleaving nucleic acids, this presence of “self-targeting” crRNAs
has led to the hypothesis that CRISPR-Cas systems may have an
additional functionality as regulatory elements.
THE TYPE II CRISPR-Cas SYSTEM AS A
POST-TRANSCRIPTIONAL REGULATOR
While all known CRISPR-Cas systems contain Cas1 and Cas2,
three different types (Type I, II, and III) are each characterized by
unique Cas proteins involved inmaturation of the crRNAs, target-
ing of foreign nucleic acid, and nucleic acid cleavage (Makarova
et al., 2011). The Type II CRISPR-Cas system is defined by
the presence of a large (∼1000–1600 amino acids) endonucle-
ase, Cas9, whose structure has recently been solved (Deltcheva
et al., 2011; Chylinski et al., 2013; Fonfara et al., 2013; Jinek
et al., 2014). Predominantly, Type II systems are encoded in
the genomes of pathogenic (including Neisseria meningitidis,
Campylobacter jejuni, Legionella pneumophila, Listeria monocyto-
genes, and Francisella novicida Makarova et al., 2011; Sampson
et al., 2013) and commensal bacteria that interact with eukaryotic
hosts. Type II CRISPR-Cas systems are further characterized by
the requirement for a unique, accessory RNA, the trans-activating
CRISPR RNA (tracrRNA), as well as RNase III, for matura-
tion of crRNAs (Figure 1) (Deltcheva et al., 2011; Jinek et al.,
2012; Chylinski et al., 2013). Cas9 is involved as a scaffold for
maturation of crRNAs, and is required for cleavage of the double-
stranded DNA target (Figure 1) (Deltcheva et al., 2011; Gasiunas
et al., 2012; Jinek et al., 2012).
Recently, we demonstrated that specific components of the
Type II CRISPR-Cas system in the Gram-negative intracellular
pathogen Francisella novicida (one of two CRISPR-Cas systems
present in this species Schunder et al., 2013) regulate the expres-
sion of an endogenous transcript encoding a bacterial lipoprotein
(BLP) (Jones et al., 2012b; Sampson et al., 2013). Cas9, together
with tracrRNA as well as a small RNA currently unique to the F.
novicida system, termed scaRNA (small, CRISPR-Cas-associated
RNA), form a dual RNA:protein complex capable of targeting the
BLP transcript (Figure 2A) (Sampson et al., 2013). Interestingly,
in contrast to its accessory role in canonical DNA targeting by
Cas9, tracrRNA displays significant sequence complementarity to
the BLP mRNA, and is thought to function in a targeting role
(Figure 2A) (Sampson et al., 2013).
scaRNA is predicted to hybridize to the tracrRNA at a
sequence identical to the CRISPR repeat, forming a dsRNA struc-
ture that may interact with Cas9 in a similar fashion as the
crRNA:tracrRNA complex within the canonical DNA-targeting
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FIGURE 2 | CRISPR-Cas-mediated gene regulation and innate immune
evasion by F. novicida. (A) A dual-RNA complex consisting of the tracrRNA
and scaRNA forms through interaction of a sequence identical to the CRISPR
repeat (pink box). This dsRNA structure is associated with F. novicida Cas9
and allows the free portion of the tracrRNA to interact through a non-identity
interaction with mRNA encoding the BLP (FTN_1103; blue). Subsequently,
the stability of the BLP mRNA is altered, possibly via catalytic activity of Cas9
(cleavage event indicated by red triangle) or by an unknown RNase (red
sector). (B) Following entry into host cells, TLR2 is capable of detecting BLPs
present in the F. novicida envelope. This leads to activation of a
proinflammatory cytokine response. (C) However, by upregulating
CRISPR-Cas components after entry and while in the phagosome, F. novicida
limits its BLP content and dampens the activation of TLR2, leading to
decreased proinflammatory cytokine signaling.
CRISPR-Cas system (Figure 2A) (Deltcheva et al., 2011; Chylinski
et al., 2013; Sampson et al., 2013). While the exact function
of the scaRNA is unknown, the current hypothesis is that it
serves to stabilize the tracrRNA in such a way that tracrRNA
can subsequently interact with the BLP transcript. This could
be through direct changes in the structure of the RNA after
hybridization, or by altering the way in which the RNAs inter-
act with Cas9. Further structural and stoichiometric studies will
help to elucidate how these RNAs interact with Cas9 to target the
BLP mRNA.
Targeting by the Cas9:tracrRNA:scaRNA machinery results
in drastically lowered levels of BLP mRNA, through a process
that alters the stability of the transcript (Sampson et al., 2013).
Exactly how the stability of the BLP mRNA is altered is unknown.
Surprisingly, this regulation does not require the amino acid
residues essential to the endonuclease activity of Cas9 proteins
(Jinek et al., 2012; Fonfara et al., 2013; Sampson et al., 2013). This
may suggest that Cas9 has redundant endonuclease motifs, each
capable of acting on the targeted BLP transcript. Alternatively, an
accessory RNase may be involved (Figure 2A). While a number
of different RNases were tested for their function in regulation
of this BLP, no single RNase mutant had an apparent regulatory
defect. One specific RNase, RNase E, could not be analyzed using
this approach since it is an essential gene (Heidrich and Vogel,
2013a). Other studies have shown that RNase E can be involved
in the modulation of mRNA stability, and it is therefore possi-
ble that it may also act as an accessory for CRISPR-Cas-mediated
regulation (Heidrich and Vogel, 2013a).
The predicted requirements for targeting the
Cas9:tracrRNA:scaRNA system to the BLP transcript also
differ considerably with those for targeting of foreign DNA by the
canonical CRISPR-Cas system. Targeting of the Cas9 endonucle-
ase to foreign DNA requires a crRNA with near 100% sequence
identity to the target (Makarova et al., 2011). Surprisingly,
crRNAs are not required for targeting of BLP mRNA (Sampson
et al., 2013), and there does not appear to be a spacer sequence
within the crRNA array that has sequence complementarity to
this transcript, making this regulatory process distinct from the
canonical DNA targeting action of Cas9. Instead, the BLP mRNA
is targeted by the tracrRNA, which only displays partial sequence
complementarity to the transcript. This may suggest that only
small stretches of sequence complementarity, or seed sequences,
are important for initiating and establishing interaction of the
tracrRNA and BLP mRNA, as has been demonstrated for nucleic
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acid targeting by other CRISPR-Cas systems (Semenova et al.,
2011; Kunne et al., 2014).
An interesting question is why BLP mRNA is apparently tar-
geted, yet the BLP gene encoded in the chromosome is not
targeted for disruption. It has been observed that targeting of
the bacterial chromosome results in loss of either that chromoso-
mal sequence or the CRISPR-Cas system itself (Stern et al., 2010;
Dy et al., 2013; Vercoe et al., 2013). Since this is not the case in
F. novicida, it strongly suggests that the DNA is not targeted for
cleavage. The imperfect complementarity between the tracrRNA
and the BLP mRNA would not be predicted to mediate targeting
of the chromosomal DNA, based on canonical CRISPR-Cas tar-
geting. Therefore, this lack of 100% complementarity could be an
important safeguard to effectively prevent DNA targeting while
nonetheless promoting targeting of mRNA. Understanding the
structural and sequence requirements of these interactions will be
important for elucidating how prokaryotes control the different
activities of CRISPR-Cas systems.
While the data discussed support a model whereby F. novi-
cida Cas9 post-transcriptionally modulates the stability of the
BLP transcript, other potential models exist as well. It is theo-
retically possible that F. novicida Cas9 binds DNA but does not
cleave it, and thereby physically blocks transcription. There is
precedence for this, at least in synthetically mutated Cas9 pro-
teins (dCas9), which lack endonuclease activity, but retain the
ability to bind DNA (Bikard et al., 2013; Cheng et al., 2013; Esvelt
et al., 2013; Mali et al., 2013; Perez-Pinera et al., 2013; Qi et al.,
2013). Upon being guided to a target gene or its promoter, dCas9
can effectively prevent transcription by blocking access of RNA
polymerase (RNAP) to the promoter and/or preventing RNAP
elongation. This system has been successfully utilized as a tool
in order to repress target genes in numerous biological systems
(Bikard et al., 2013; Cheng et al., 2013; Esvelt et al., 2013; Mali
et al., 2013; Perez-Pinera et al., 2013; Qi et al., 2013). A lack of F.
novicida Cas9 endonuclease activity would be consistent with the
observation that none of the conserved residues within any of the
predicted endonuclease motifs of the protein were necessary for
repression of the BLP transcript (Sampson et al., 2013). However,
recent data demonstrates that, in fact, F. novicida Cas9 is fully
capable of targeting and cleaving DNA substrates, at least in vitro
(Fonfara et al., 2013). The finding that F. novicida Cas9 can cleave
DNA, yet the BLP gene is nonetheless present in the genome
and the protein is produced (Jones et al., 2012b; Fonfara et al.,
2013; Sampson and Weiss, 2013; Sampson et al., 2013), supports
the hypothesis that the DNA is not targeted while BLP mRNA
is. Furthermore, this alternative transcription inhibition model
would not explain the observed changes in the BLP transcript’s
stability after treatment of cells with rifampin which blocks tran-
scription, nor the presence of the BLP transcript in association
with Cas9 (Sampson et al., 2013).
Assuming that F. novicida Cas9 does target RNA, it is possible
that this is not a feature common to all Cas9 proteins. While sim-
ilar to other Cas9 proteins, F. novicida Cas9 does have regions of
significant sequence dissimilarity which may alter its function in
targeting DNA or RNA (Makarova et al., 2011; Chylinski et al.,
2013; Fonfara et al., 2013; Sampson et al., 2013). There is prece-
dence for such a scenario in Type III CRISPR-Cas systems. The
Type III-A and III-B systems have slight differences in the struc-
tures of their targeting complexes (Cascade) which may account
for their differential ability to target DNA substrates (III-A) or
RNA substrates (III-B) (Heidrich and Vogel, 2013b; Rouillon
et al., 2013; Spilman et al., 2013; Staals et al., 2013). Continued
dissection of the molecular mechanism of Cas9 function will
provide answers to these and other critical remaining questions,
in particular focusing on structure and function comparisons
between Cas9 variants (Fonfara et al., 2013; Jinek et al., 2014;
Sternberg et al., 2014).
ROLE OF CRISPR-Cas-MEDIATED GENE REGULATION IN
PATHOGENESIS
The bacterial pathogen Francisella novicida, a relatively rare
cause of disease in humans, evades detection by the host innate
immune system and replicates within host cells (Jones et al.,
2012a). F. novicida has numerous mechanisms by which to sub-
vert the function of host macrophages as well as other cells. Once
taken up by macrophages, this pathogen enters the phagosome,
a compartment containing numerous antimicrobials as well as
innate immune recognition receptors (Jones et al., 2012a). One
such receptor is Toll-like Receptor 2 (TLR2), which detects BLPs
(Aliprantis et al., 1999; Brightbill et al., 1999). Activation of TLR2
results in a pro-inflammatory response which recruits and acti-
vates immune cells, and acts to combat and clear the bacterial
pathogen.
Utilizing Cas9, tracrRNA, and scaRNA as regulators, F. novi-
cida represses the expression of the targeted BLP, significantly
lowering overall BLP levels in its envelope by roughly 2-fold
(Figure 2C) (Jones et al., 2012b; Sampson et al., 2013). This
allows the pathogen to effectively dampen TLR2 activation,
facilitating its survival within the host. In the absence of this
CRISPR-Cas-mediated regulation, F. novicida elicits a significant
TLR2-dependent inflammatory response (Figure 2B), as revealed
by the fact that cas9, tracrRNA, and scaRNA deletion mutants
induce a much greater inflammatory response than wild-type
bacteria (Sampson et al., 2013). Not only is this inflammatory
response dependent on TLR2, but it is also dependent on the
over-expression of BLP, as strains lacking both the regulatory
components and the BLP elicit a response that is limited to
near wild-type levels (Jones et al., 2012b; Sampson et al., 2013).
Furthermore, deletion mutants lacking these CRISPR-Cas com-
ponents are highly attenuated (over 1000 fold) (Sampson et al.,
2013). In addition, cas9, tracrRNA, and scaRNA deletion mutants
are unable to induce a lethal infection of mice, further empha-
sizing their importance as regulators of virulence in F. novicida
(Sampson et al., 2013).
While the F. novicida CRISPR-Cas system is currently the only
known example of a Cas9 system acting naturally in a regulatory
capacity, there have been observations of other species utilizing
Cas9 as a virulence factor. In a human lung epithelial cell model,
Cas9 is essential for attachment of Neisseria meningitidis to the
host cell surface, as well as both invasion and intracellular repli-
cation (Sampson et al., 2013). Additionally, Cas9 is essential for
attachment and invasion of Campylobacter jejuni in a colorectal
epithelial cell model (Louwen et al., 2013). The precise mech-
anism by which Cas9 functions as a virulence factor in these
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organisms is not yet known. However, based on the established
role of Cas9 as a regulator of gene expression in F. novicida,
it is likely that Cas9 acts in combination with tracrRNA or an
alternative, unidentified small RNA, to regulate the levels of spe-
cific transcripts, ultimately leading to the control of virulence
properties.
Additionally, the role of Cas9 as a Campylobacter virulence
factor correlated with specific strains encoding the Cst-II sia-
lyltransferase, and which produce a sialylated lipooligosaccha-
ride (Louwen et al., 2013). It is interesting to hypothesize that
CRISPR-Cas-mediated regulation may act not only to allow
C. jejuni to efficiently attach to host cells, but also to mask its sur-
face from detection by host receptors, and prevent activation of
host defenses, such as the complement system. Since the known
regulatory target of Cas9 in Francisella is a membrane BLP, and
these additional examples of a contribution of Cas9 to virulence
traits involve attachment of the bacterial cell to the host cell sur-
face, it is interesting to speculate that CRISPR-Cas systems may
generally act as regulators of envelope composition and structure.
ROLE OF CRISPR-Cas SYSTEMS IN THE RESPONSE TO
ENVELOPE STRESS
The regulation of the bacterial envelope is especially important
during times of membrane stress, in order to resist and combat
this stress, and to promote bacterial survival. Interestingly, it has
been observed that expression of CRISPR-Cas components in sev-
eral bacterial species can be induced following envelope stress.
For instance, in E. coli when a membrane-targeted GFP is over-
expressed, the downstream envelope stress response triggers the
upregulation of CRISPR-Cas system expression (Perez-Rodriguez
et al., 2011). Additionally, CRISPR-Cas systems in other bacte-
rial and archaeal species, including Streptococcus thermophilus and
Sulfolobus islandicus, have been shown to be induced in the pres-
ence of bacteriophage (Young et al., 2012; Quax et al., 2013),
suggesting that the envelope stress which occurs during attach-
ment and entry of bacteriophage may be a signal to activate
CRISPR-Cas systems. Envelope stress may further serve as a sig-
nal of increased cell permeability, a condition that would likely
increase the chance of foreign nucleic acid uptake. Thus, induc-
tion of CRISPR-Cas systems at times of envelope stress might
act to prepare the cell for incoming foreign nucleic acid and
prevent acquisition of harmful genetic elements. In addition,
since CRISPR-Cas systems have been shown to regulate enve-
lope components, and these systems are induced in response to
membrane stress, it is tempting to speculate that the regulatory
roles of these machineries may also serve to combat this stress.
For example, the regulation of membrane BLP composition, as
observed in F. novicida (Jones et al., 2012b; Sampson et al., 2013),
in addition to promoting evasion of the host innate immune
response, may act to alter or enhance the integrity of the bacterial
envelope.
ROLE OF OTHER CRISPR-Cas COMPONENTS AND SYSTEMS
IN BACTERIAL PHYSIOLOGY
In addition to Cas9’s role as a virulence factor in the bacterial
pathogens F. novicida, N. meningitidis, and C. jejuni, CRISPR-Cas
systems in other bacteria have been identified as having potential
roles in virulence as well. Cas2, present within a Type II CRISPR-
Cas system, is important for the ability of Legionella pneumophila
to replicate within amoebae (Gunderson and Cianciotto, 2013).
Since amoebae are thought to be important for L. pneumophila
survival in the environment (Rowbotham, 1986; Fields, 1996;
Abu Kwaik et al., 1998), the role of Cas2 in intracellular amoe-
bic survival may play a role in its survival in the environment.
In addition, in strains encoding the Type II system, it may even
promote subsequent transmission to human hosts (Gunderson
and Cianciotto, 2013). Exactly how Cas2 functions to medi-
ate Legionella intracellular survival in amoebae is unknown. It
is hypothesized to have an alternative function in conjunction
with currently unidentified small RNAs, either in their pro-
cessing or in the alteration of mRNA stability (Gunderson and
Cianciotto, 2013). Interestingly, Cas9 has no observed role in
L. pneumophila survival in amoebae (Gunderson and Cianciotto,
2013). Conversely, Cas2 has no observed role in the ability of
F. novicida to modulate BLP expression, nor intracellular survival
or virulence (Sampson et al., 2013), demonstrating that while
Type II CRISPR-Cas systems have similar genetic architectures,
different species may have co-opted alternative components for
functions distinct from defense against foreign nucleic acids.
Type I CRISPR-Cas systems have also been implicated in
aspects of bacterial physiology beyond their now canonical func-
tion in foreign nucleic acid defense. The Type I CRISPR-Cas
system in Pseudomonas aeruginosa has been shown to play a role
in modulating the production of biofilms (Zegans et al., 2009;
Cady and O’Toole, 2011). While the exact regulatory mechanism
has not been elucidated, the data suggest that the CRISPR-Cas
system interacts with a specific gene within a chromosomally
integrated prophage, inhibiting biofilm formation (Zegans et al.,
2009; Cady and O’Toole, 2011). It is unclear if the CRISPR-Cas
system targets the chromosomal DNA or the prophage transcript,
but it is known that this regulation requires the Cas proteins
involved in crRNA maturation, as well as those involved in tar-
geting/degradation. Further, this regulatory activity depends on
a specific crRNA with sequence identity to the prophage gene
(Zegans et al., 2009; Cady and O’Toole, 2011). Interestingly, this
crRNA does not exhibit 100% complementarity to its regulatory
target. Similar to F. novicida Cas9 targeting of BLP mRNA, this
is a non-identity interaction, perhaps providing a reason for why
chromosomal targeting by the Pseudomonas CRISPR-Cas system
would not result in a lethal event. Given that biofilm formation
is a critical aspect of the pathogenic life cycle of P. aeruginosa
(Gellatly and Hancock, 2013), it is likely that this example of
CRISPR-Cas-mediated regulation plays a vital role in infection.
Another Type I CRISPR-Cas system with regulatory attributes
is found in the soil bacterium Myxococcus xanthus. Three genes,
devT, devR, and devS, corresponding to cas8, cas7, and cas5
respectively, have been shown to be necessary for sporulation
and fruiting body development (Thony-Meyer and Kaiser, 1993;
Boysen et al., 2002; Viswanathan et al., 2007). Specifically, it was
observed that devT (cas8) mutants had significant delays in aggre-
gation, sporulation, and chemotaxis. This correlated with low
levels of transcript for a necessary activator of fruiting body for-
mation (Boysen et al., 2002). It is not known if the crRNA array
is necessary for fruiting body formation, however it does encode
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two spacers with complementarity to chromosomal loci, one of
which could hybridize to an integrase of a Myxococcus bacterio-
phage and the other that could hybridize to a cas gene in an
exogenous CRISPR-Cas locus (Viswanathan et al., 2007). How
these CRISPR-Cas components interact to ultimately perform
this regulatory function remains to be elucidated.
Additionally, the Archaeal Type I system encoded by Pelobacter
sp. has been demonstrated to play a role in the regulation of
gene expression as well (Aklujkar and Lovley, 2010). These species
contain a spacer within the crRNA array with sequence iden-
tity to the gene encoding a histidyl-tRNA (Aklujkar and Lovley,
2010). Upon expression of this self-targeting spacer within a
species related to Pelobacter encoding a similar CRISPR-Cas sys-
tem (but lacking the self-targeting spacer), it was observed that
histidyl-tRNA transcript levels were reduced, and that the bac-
teria exhibited a growth defect (as expected if protein synthe-
sis is slowed by lower levels of a critical tRNA) (Aklujkar and
Lovley, 2010). The precise mechanism and how the cas genes
are involved in this process is yet unknown. In addition to these
examples of self-targeting spacers involved in gene regulation
through unknown mechanisms, there are numerous examples of
self-targeting crRNA spacers (Stern et al., 2010). However, it is
unclear if they are indeed involved in regulation. For example,
Aggregatibacter actinomycetemcomitans encodes a spacer puta-
tively targeting the important metabolic enzyme glgP (Jorth and
Whiteley, 2012). While this crRNA is transcribed and processed,
it is not known if it acts as a regulator of glgP production (Jorth
andWhiteley, 2012). Future study of such spacers will likely reveal
a plethora of regulatory functions for CRISPR-Cas systems in
diverse bacteria.
There also exist examples in which crRNAs may have regula-
tory roles, even in the absence of Cas proteins. Listeria monocyto-
genes encodes an isolated crRNA locus, consisting of five identical
repeats, and four unique spacer sequences (Mandin et al., 2007;
Sesto et al., 2014). This locus, termed rliB, is not adjacent to
any known cas genes, and is present even within L. monocyto-
genes strains that are devoid of any cas genes (Mandin et al.,
2007; Sesto et al., 2014). rliB is processed by the bifunctional
polynucleotide phosphorylase (PNPase), which has exoribonu-
clease activity (Sesto et al., 2014). The rliB crRNA has significant
sequence complementarity to the transcripts for a two com-
ponent system, a transcriptional regulator, and the feoAB iron
transport system (Mandin et al., 2007). In fact, rliB is capable
of hybridizing to and repressing production of these transcripts
(Mandin et al., 2007). Since feoAB is an important virulence factor
in numerous organisms, it is likely that rliB plays an impor-
tant role in the virulence of L. monocytogenes. Interestingly, this
orphaned system is still capable of acting canonically against plas-
mid transformation, provided there are cas genes produced in an
exogenous locus. However it is unknown if this occurs through
targeting of DNA or RNA substrates (Sesto et al., 2014).
While the aforementioned examples of alternative CRISPR-
Cas function focus on regulatory roles, there may be more indi-
rect mechanisms by which CRISPR-Cas systems contribute to
virulence. For example, it has been observed that both Cas1 and
the crRNA array in the Type I CRISPR-Cas system of E. coli
play a role in DNA repair (Babu et al., 2011). Given that Cas1
is present in all known CRISPR-Cas systems, it is interesting to
think that this gene may have a broad function in DNA repair
in other species as well. Furthermore, bacterial DNA damage is
thought to occur due to the action of specific host defenses dur-
ing infection, in particular the production of radical nitrogen
and oxygen species (Suvarnapunya et al., 2003). It is therefore
interesting to consider that Cas1 may be able to provide bacte-
rial pathogens some redundancy in their capability to repair DNA
damage incurred during infection.
CONCLUSIONS
While now very well established to play roles in bacteriophage
and foreign genetic element defense, the alternative functions that
CRISPR-Cas systems play in the ability of bacterial pathogens
to evade and dampen host defenses, and ultimately survive and
replicate within the host, have only recently begun to be appre-
ciated. Furthermore, with the continued observations that some
CRISPR-Cas systems can target RNA substrates (Hale et al., 2009;
Spilman et al., 2013; Terns and Terns, 2013), this raises the strong
possibility that regulation of endogenous genes by CRISPR-Cas
systems can occur without the negative consequences of target-
ing the bacterial chromosome (Stern et al., 2010; Dy et al., 2013;
Vercoe et al., 2013). Given that CRISPR-Cas systems are encoded
in the genomes of numerous prokaryotes (including ∼45% of
bacteria and∼83% of Archaea) (CRISPRdb, 23 Jan 2014) (Grissa
et al., 2007), it is likely that numerous examples of alternative
functions in gene regulation, virulence and physiology will be
uncovered in the future.
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